Unveiling the Anticancer Potential: Computational Exploration of Nitrogenated Derivatives of (+)-Pancratistatin as Topoisomerase I Inhibitors
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910779 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Magdi Awadalla Mohamed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia. Hauptthemen laut MEDLINE: Topoisomerase I Inhibitors, Amaryllidaceae Alkaloids, Molecular Docking Simulation, DNA Topoisomerases, Type I. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Deanship of Graduate Studies and Scientific Research at Jouf University.
Abstract (Originalsprache)
Cancer poses a substantial global health challenge, driving the need for innovative therapeutic solutions that offer improved effectiveness and fewer side effects. Topoisomerase I (Topo I) has emerged as a validated molecular target in the pursuit of developing anticancer drugs due to its critical role in DNA replication and transcription. (+)-Pancratistatin (PST), a naturally occurring compound found in various Amaryllidaceae plants, exhibits promising anticancer properties by inhibiting Topo I activity. However, its clinical utility is hindered by issues related to limited chemical availability and aqueous solubility. To address these challenges, molecular modelling techniques, including virtual screening, molecular docking, molecular mechanics with generalised born and surface area solvation (MM-GBSA) calculations, and molecular dynamics simulations were utilised to evaluate the binding interactions and energetics of PST analogues with Topo I, comparing them with the well-known Topo I inhibitor, Camptothecin. Among the compounds screened for this study, nitrogenated analogues emerged as the most encouraging drug candidates, exhibiting improved binding affinities, favourable interactions with the active site of Topo I, and stability of the protein-ligand complex. Structural analysis pinpointed key molecular determinants responsible for the heightened potency of nitrogenated analogues, shedding light on essential structural modifications for increased activity. Moreover, in silico absorption, distribution, metabolism, excretion, and toxicity (ADMET) predictions highlighted favourable drug-like properties and reduced toxicity profiles for the most prominent nitrogenated analogues, further supporting their potential as effective anticancer agents. In summary, this screening study underscores the significance of nitrogenation in augmenting the anticancer efficacy of PST analogues targeting Topo I. The identified lead compounds exhibit significant potential for subsequent experimental validation and optimisation, thus facilitating the development of novel and efficacious anticancer therapeutics with enhanced pharmacological profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 42421, Saudi Arabia.
- Nursing Administration & Education Department, College of Nursing, Jouf University, Sakaka 72388, Saudi Arabia.
- Department of Pathology, College of Medicine, Umm Alqura University, Algunfudah 21912, Saudi Arabia.
- Deparment of Physiology, College of Medicine, Umm Alqura University, Alqunfudah 21912, Saudi Arabia.
- Department of Medical Oncology, Prince Mohammad Medical City, Aljouf 11443, Saudi Arabia.
ORCID-Profile: Magdi Awadalla Mohamed, Tilal Elsaman, Abozer Y Elderdery, Abdullah Alsrhani, Majed Mowanes Alruwaili, Jeremy Mills
Förderung
- The Deanship of Graduate Studies and Scientific Research at Jouf University
Zitieren
APA
Mohamed, M. A., Elsaman, T., Elderdery, A. Y., Alsrhani, A., Ghanem, H. B., Alruwaili, M. M., Hamza, S. M. A., Mekki, S. E. I., Alotaibi, H. A., & Mills, J. (2024). Unveiling the Anticancer Potential: Computational Exploration of Nitrogenated Derivatives of (+)-Pancratistatin as Topoisomerase I Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910779
Vancouver
Mohamed MA, Elsaman T, Elderdery AY, Alsrhani A, Ghanem HB, Alruwaili MM, et al. Unveiling the Anticancer Potential: Computational Exploration of Nitrogenated Derivatives of (+)-Pancratistatin as Topoisomerase I Inhibitors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910779
BibTeX
@article{Mohamed2024,
author = {Mohamed, Magdi Awadalla and Elsaman, Tilal and Elderdery, Abozer Y and Alsrhani, Abdullah and Ghanem, Heba Bassiony and Alruwaili, Majed Mowanes and Hamza, Siddiqa M A and Mekki, Salma Elhadi Ibrahim and Alotaibi, Hazim Abdullah and Mills, Jeremy},
title = {Unveiling the Anticancer Potential: Computational Exploration of Nitrogenated Derivatives of (+)-Pancratistatin as Topoisomerase I Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910779}
}
EUVIMED